Cue Biopharma (CUE) Revenue (2017 - 2026)
Cue Biopharma (CUE) revenue from Mar 31, 2017 to Mar 31, 2026. The TTM Cue Biopharma (CUE) revenue is $33M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Revenue
Quarterly Revenue
Cue Biopharma (CUE) Revenue CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +309.12% |
| 3 Years TTM | +320.56% |
| 5 Years TTM | +53.75% |
Annual Revenue change of Cue Biopharma (CUE)
| Year | Revenue | Change |
|---|---|---|
| 2026 | $5.69M | -79.29% |
| 2025 | $27M | +195.69% |
| 2024 | $9.29M | +69.22% |
| 2023 | $5.49M | +339.20% |
| 2022 | $1.25M | -91.63% |
| 2021 | $15M | +374.29% |
| 2020 | $3.15M | -8.96% |
| 2019 | $3.46M | +203.51% |
| 2018 | $1.14M | N/A |
| 2017 | $0 | N/A |
Comparison Cue Biopharma (CUE) five years revenue CAGR with competitors
Cue Biopharma (CUE) five years revenue CAGR is 53.77%.